Last reviewed · How we verify

Same Bupivacaine Concentration

University of Chile · FDA-approved active Small molecule

Same Bupivacaine Concentration is a Local anesthetic Small molecule drug developed by University of Chile. It is currently FDA-approved for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks.

Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. Used for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks.

At a glance

Generic nameSame Bupivacaine Concentration
SponsorUniversity of Chile
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Bupivacaine reversibly binds to and blocks voltage-gated sodium channels on the inner surface of nerve cell membranes, preventing depolarization and action potential propagation. This results in local anesthesia and loss of sensation in the infiltrated tissue. The drug is long-acting due to its high lipophilicity and protein binding, allowing sustained neural blockade.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Same Bupivacaine Concentration

What is Same Bupivacaine Concentration?

Same Bupivacaine Concentration is a Local anesthetic drug developed by University of Chile, indicated for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks.

How does Same Bupivacaine Concentration work?

Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

What is Same Bupivacaine Concentration used for?

Same Bupivacaine Concentration is indicated for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Nerve blocks, Epidural and spinal anesthesia.

Who makes Same Bupivacaine Concentration?

Same Bupivacaine Concentration is developed and marketed by University of Chile (see full University of Chile pipeline at /company/university-of-chile).

What drug class is Same Bupivacaine Concentration in?

Same Bupivacaine Concentration belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Same Bupivacaine Concentration in?

Same Bupivacaine Concentration is FDA-approved (marketed).

What are the side effects of Same Bupivacaine Concentration?

Common side effects of Same Bupivacaine Concentration include Systemic toxicity (CNS effects: tremor, seizures), Cardiovascular effects (hypotension, arrhythmias), Allergic reactions, Methemoglobinemia.

What does Same Bupivacaine Concentration target?

Same Bupivacaine Concentration targets Voltage-gated sodium channels and is a Local anesthetic.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing